Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
Business Wire India Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for…
